BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Zhao J, Fang LJ, Setchell KD, Chen R, Li LT, Wang JS. Primary ∆4-3-oxosteroid 5β-reductase deficiency: Two cases in China. World J Gastroenterol 2012; 18(47): 7113-7117 [PMID: 23323017 DOI: 10.3748/wjg.v18.i47.7113]
URL: https://www.wjgnet.com/1007-9327/full/v18/i47/7113.htm
Number Citing Articles
1
A. S. Knisely. Pathology of Pediatric Gastrointestinal and Liver Disease2014; : 445 doi: 10.1007/978-3-642-54053-0_11
2
Jing Zhao, Yi-Ling Qiu, Li Wang, Zhong-Die Li, Xin-Bao Xie, Yi Lu, Kenneth D.R. Setchell, Ye Cheng, Qing-He Xing, Jian-She Wang. Recurrent AKR1D1 c.580-13T>A VariantThe Journal of Molecular Diagnostics 2023; 25(4): 227 doi: 10.1016/j.jmoldx.2023.01.004
3
T.M. Penning. Comprehensive Toxicology2018; : 164 doi: 10.1016/B978-0-12-801238-3.64092-8
4
Neng-Li Wang, Yi Lu, Jing-Yu Gong, Xin-Bao Xie, Jing Lin, Kuerbanjiang Abuduxikuer, Mei-Hong Zhang, Jian-She Wang. Molecular findings in children with inherited intrahepatic cholestasisPediatric Research 2020; 87(1): 112 doi: 10.1038/s41390-019-0548-8
5
Trevor Martin Penning. Reference Module in Biomedical Sciences2024;  doi: 10.1016/B978-0-323-95488-4.00010-3
6
Mo Chen, Trevor M. Penning. 5β-Reduced steroids and human Δ4-3-ketosteroid 5β-reductase (AKR1D1)Steroids 2014; 83: 17 doi: 10.1016/j.steroids.2014.01.013
7
Aathira Ravindranath, Moinak Sen Sarma, Surender Kumar Yachha. Bile acid synthetic defects: Simplified approach in a nutshellHepatobiliary & Pancreatic Diseases International 2020; 19(1): 80 doi: 10.1016/j.hbpd.2019.09.003
8
Akihiko Kimura, Tatsuki Mizuochi, Hajime Takei, Akira Ohtake, Jun Mori, Kunihiro Shinoda, Takuji Hashimoto, Mureo Kasahara, Takao Togawa, Tsuyoshi Murai, Takashi Iida, Hiroshi Nittono. Bile Acid Synthesis Disorders in Japan: Long-Term Outcome and Chenodeoxycholic Acid TreatmentDigestive Diseases and Sciences 2021; 66(11): 3885 doi: 10.1007/s10620-020-06722-4
9
Mei-Hong Zhang, Kenneth DR Setchell, Jing Zhao, Jing-Yu Gong, Yi Lu, Jian-She Wang. Δ4-3-oxosteroid-5β-reductase deficiency: Responses to oral bile acid therapy and long-term outcomesWorld Journal of Gastroenterology 2019; 25(7): 859-869 doi: 10.3748/wjg.v25.i7.859
10
Antoine Gardin, Mathias Ruiz, Jan Beime, Mara Cananzi, Margarete Rathert, Barbara Rohmer, Enke Grabhorn, Marion Almes, Veena Logarajah, Luis Peña-Quintana, Thomas Casswall, Amaria Darmellah-Remil, Ana Reyes-Domínguez, Emna Barkaoui, Loreto Hierro, Carolina Baquero-Montoya, Ulrich Baumann, Björn Fischler, Emmanuel Gonzales, Anne Davit-Spraul, Sophie Laplanche, Emmanuel Jacquemin. ∆4-3-oxo-5β-reductase deficiency: favorable outcome in 16 patients treated with cholic acidOrphanet Journal of Rare Diseases 2023; 18(1) doi: 10.1186/s13023-023-02984-z
11
Tea Lanišnik Rižner, Trevor M. Penning. Role of aldo–keto reductase family 1 (AKR1) enzymes in human steroid metabolismSteroids 2014; 79: 49 doi: 10.1016/j.steroids.2013.10.012
12
Peter T. Clayton. Inborn Metabolic Diseases2016; : 465 doi: 10.1007/978-3-662-49771-5_33
13
Hui-Hui Wang, Fei-Qiu Wen, Dong-Ling Dai, Jian-She Wang, Jing Zhao, Kenneth DR Setchell, Li-Na Shi, Shao-Ming Zhou, Si-Xi Liu, Qing-Hua Yang. Infant cholestasis patient with a novel missense mutation in the <i>AKR1D1</i> gene successfully treated by early adequate supplementation with chenodeoxycholic acid: A case report and review of the literatureWorld Journal of Gastroenterology 2018; 24(35): 4086-4092 doi: 10.3748/wjg.v24.i35.4086
14
Nikolaos Nikolaou, Leanne Hodson, Jeremy W. Tomlinson. The role of 5-reduction in physiology and metabolic disease: evidence from cellular, pre-clinical and human studiesThe Journal of Steroid Biochemistry and Molecular Biology 2021; 207: 105808 doi: 10.1016/j.jsbmb.2021.105808
15
Mo Chen, Yi Jin, Trevor M. Penning. In-Depth Dissection of the P133R Mutation in Steroid 5β-Reductase (AKR1D1): A Molecular Basis of Bile Acid DeficiencyBiochemistry 2015; 54(41): 6343 doi: 10.1021/acs.biochem.5b00816
16
Peter T. Clayton. Inborn Metabolic Diseases2022; : 705 doi: 10.1007/978-3-662-63123-2_38